Evaluation of impaired β-cell function in nonobese-diabetic (NOD) mouse model using bioluminescence imaging

Keyphrases

• Cell Function 100%
• Type 1 Diabetes Mellitus (T1DM) 100%
• Diabetic Mouse Model 100%
• Non-obese Diabetic Mice 100%
• Bioluminescence Imaging 100%
• Type I Diabetes 66%
• Luciferase Gene 66%
• Luminescence 33%
• Insulin 33%
• In Vivo Monitoring 33%
• Luciferase 33%
• Immune Response 33%
• Inflammatory Process 33%
• Inflammatory Cytokines 33%
• Transgenic Mice 33%
• Pathological Conditions 33%
• Pathological Changes 33%
• Bioluminescence 33%
• Functional Impairment 33%
• Pancreatic Cells 33%
• Islet 33%
• Cell Dysfunction 33%
• Cell Destruction 33%
• Protein Level 33%
• Metabolic Changes 33%
• Imaging Approach 33%
• Pre-diabetes (pre-DM) 33%
• Cellular Level 33%
• Cell Mass 33%
• Metabolic Status 33%
• Extracellular ATP (eATP) 33%
• ATP Level 33%
• Non-obese Diabetic 33%
• Selective Expression 33%
• Doxycycline-inducible 33%
• Firefly Luciferase 33%
• Non-invasive Probes 33%

Biochemistry, Genetics and Molecular Biology

• Luciferase 100%
• Mouse Model 100%
• Cell Function 100%
• Nonobese Diabetic Mouse 100%
• Bioluminescence Imaging 100%
• Adenosine Triphosphate 50%
• Inflammatory Cytokine 25%
• Bioluminescence 25%
• Transgenic Mouse 25%
• Cell Destruction 25%

Immunology and Microbiology

• Cell Function 100%
• Mouse Model 100%
• Bioluminescence 100%
• Nonobese Diabetic Mouse 100%
• Inflammatory Cytokine 33%
• Transgenic Mouse 33%
• Cell Destruction 33%